NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya

NCT07764796

RecruitingNA

Sponsor: Emory University

Conditions: Breast Carcinoma

Interventions: Best Practice, Discussion, Interview - Stakeholder, Interview - Key Informant, Interview - Ancillary studies

Countries: United States

This clinical trial develops and studies how well mobile health (m-Health) patient navigation (PN) strategies work to improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya. Although highly curable, breast cancer kills thousands of women in developing countries yearly. Mammography (MMG) is used for the early detection of breast cancer by creating a picture of the breast using film or a computer. Despite the availability of MMG in all 47 counties in Kenya, screening remains low in eligible women. Early detection of breast cancer may also be improved through access to high quality clinical breast exams (CBE). However, primary care providers in Kenya face barriers to incorporating CBE into practice, including limited patient awareness of breast cancer screening. m-Health uses applications on mobile phones to deliver PN directly to the patients. The PN strategies in this study include digital platforms and tools to help with education, reminders, navigation, and motivation around breast cancer screening. This may improve screening and the early detection of breast cancer in women accessing primary care clinics in Kenya.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* AIM 1: All members of BREAKTHROUGH's Stakeholder Advisory Board (SAB) breast cancer working group
* AIM 1: Participants (patients and health providers) from primary health care clinics in Nairobi County
* AIM 1: Will include women (patients) aged over 35 years and speak either Kiswahili or English
* AIM 1: Include women who:

  * Have never undergone MMG screening
  * Previously undergone MMG screening
  * Experienced breast abnormalities and have been referred for or undergone diagnostic investigations
  * Are currently undergoing or have received breast cancer treatment
* AIM 1: Health care providers and breast screening facility staff (i.e. primary care clinic nurses, MMG clinic staff and technicians) will also be recruited
* AIM 2: Will engage with a diverse group of local and national interagency stakeholders, Nairobi County health leadership, and health providers across different levels of the health system
* AIM 3: Women aged 35 years and older who are able to provide informed consent who are attending the outpatient clinics for primary health care
* AIM 4: Members of SAB breast cancer group, health facilities leadership (all health facility levels)

Exclusion Criteria:

* AIM 1: Those who will be unwilling to consent and those who are unable to consent will be excluded from the study
* AIM 2: Those who will be unwilling to consent and those who are unable to consent will be excluded from the study
* AIM 3: Women undergoing breast cancer treatment and women aged 70 years and above will be excluded
* AIM 4: Members of SAB breast cancer group, and health facilities leadership who will be unwilling and unable to consent will be excluded

Locations (1)

Atlanta, Georgia, United States